Sources revealed that an error occurred in Johnson & Johnson’s coronavirus vaccine manufacturing plant, which affected the raw materials for 15 million doses of vaccine. The accident occurred at the company’s Emergent BioSolutions Inc. facility in Baltimore, USA.
According to Bloomberg News, Johnson & Johnson pointed out in a statement that a batch of drugs failed the quality test. “The quality control process found that a batch of drugs at the Emergent BioSolutions facility did not meet the quality standards. The facility has not yet been approved for use in the manufacture of coronavirus vaccines. Drug”.
The statement also mentioned that the company has reported the matter to the US Food and Drug Administration (FDA).
Nevertheless, the above-mentioned sources believe that this will not affect the progress of vaccination in the United States. President Biden is expected to provide coronavirus vaccines to adults across the United States in May.